NDC 11523-0122-01 - MiraLAX Orange Flavor
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11523-0122
- Requested NDC
- 11523-0122-01
- Package NDCs from labels
- 11523-0122-2, 11523-0122-1, 11523-0122-01
- Manufacturer
- Bayer HealthCare LLC.
- Effective date
- 2025-12-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MiraLAX ® Orange Flavor | Bayer HealthCare LLC. | 2025-12-04 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-0122-1 | MiraLAX Orange Flavor | 238 g in 1 BOTTLE | POWDER, FOR SOLUTION | 238 | 3 | |
| 11523-0122-2 | MiraLAX Orange Flavor | 119 g in 1 BOTTLE | POWDER, FOR SOLUTION | 119 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11523-0122 | MIRALAX ORANGE FLAVOR (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [BAYER HEALTHCARE LLC.] | 2 | Current NDC, 2 package rows | 20241208_0a5b2121-928f-8f49-e063-6394a90a8aaf.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Equate ClearLAX | POLYETHYLENE GLYCOL 3350 | WALMART INC. | c5c13378-3c08-415f-8ab4-8a18d6300ca8 | 2022-09-08 | Warnings | ANDA090685 876193 G2M7P15E5P |
| injoy constipation relief | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | b2414517-04bf-4f29-951e-b867855078c3 | 2022-08-19 | Warnings | ANDA090685 876193 G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 0858a914-4812-4e4d-82f8-ecf93d43ef3b | 2022-07-01 | Warnings | ANDA090685 G2M7P15E5P |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 199d6173-3fad-49e4-88fe-bde7223ed4c3 | 2022-06-01 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol | POLYETHYLENE GLYCOL | BluePoint Laboratories | c4cae70c-68da-0bbc-e053-2a95a90a395a | 2021-09-20 | Warnings | G2M7P15E5P |
| signature care clearlax | POLYETHYLENE GLYCOL 3350 | Safeway | 91d2e780-2aae-411c-b7b3-820302f0f63e | 2021-05-13 | Warnings | ANDA090685 876193 G2M7P15E5P |
| POLYETHYLENE GLYCOL 3350 NF | POLYETHYLENE GLYCOL 3350 | SUNRISE PHARMACEUTICAL, INC | ce5197a1-2677-4ffb-aef2-9221b28ebd23 | 2020-01-22 | Warnings | 876193 G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.